Friday, November 22, 2024
HomeTagsPrecision immunotherapy

precision immunotherapy

Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer

Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, announced the appointment of Kathy Bergsteinsson, MBA,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics